FindMyRecallSubscribe
Class II: temporary or reversible health riskTerminated

Glenmark Pharmaceuticals Estradiol Vaginal Inserts Recall

Estradiol Vaginal Inserts, USP, 10 mcg, Rx only, packaged in a) 8 count (NDC 68462-711-…

Glenmark Pharmaceuticals Inc., USA · Mahwah, NJ

Risk level
Class II
Reported by FDA
Jan 16, 2019
Recall ID
D-0350-2019
Check your lot numberHow we source this data

Summary

Glenmark Pharmaceuticals recalled Estradiol Vaginal Inserts starting Dec 26, 2018. The FDA classified it as Class II (temporary or reversible health risk) and published enforcement report D-0350-2019 on Jan 16, 2019. Reason: Defective Delivery System: Customer complaints of malfunctioning plunger of the applicator. Status: Terminated.

Why it was recalled

Defective Delivery System: Customer complaints of malfunctioning plunger of the applicator

Product description

Estradiol Vaginal Inserts, USP, 10 mcg, Rx only, packaged in a) 8 count (NDC 68462-711-71) and b) 18 count (NDC 68462-711-88) cartons, Manufactured by: Glenmark Pharmaceuticals, Ltd., Colvale, Goa India, Manufactured for: Glenmark Pharmaceuticals, Inc., USA Mahwah, NJ

Lot numbers, UPCs & expiration codes

Batch numbers: a) 20180393, exp. date 01/31/2020, 20180424, exp. date 02/29/2020, 20180425, exp. date 02/29/2020, 20180427, exp. date 02/29/2020; b) 20180338, exp. date 12/31/2019, 20180386, exp. date 01/31/2020

Where it was sold

Product was distributed to 5 retailers and 4 distributors throughout the United States who may have further distributed the recalled product.

What to do if you have this product

  • Compare the lot number and expiration date on your package with the codes above.
  • Don't stop taking a prescription medicine on your own. Call your pharmacist or doctor; they can confirm whether your supply is affected and arrange a replacement.
  • If you have symptoms you think are related, contact your doctor. In an emergency call 911.
  • Report side effects to FDA MedWatch at 1-800-FDA-1088.

Recall details

Recall number
D-0350-2019
Classification
Class II
Status
Terminated
Recall initiated
Dec 26, 2018
FDA report date
Jan 16, 2019
Quantity
96,240 applicators
Recall type
Voluntary: Firm initiated
Recalling firm
Glenmark Pharmaceuticals Inc., USA

Original FDA data

Every field from FDA enforcement report D-0350-2019, exactly as published.

Show all FDA fields
City
Mahwah
State
NJ
Status
Terminated
Country
United States
Event ID
81876
Address
750 Corporate Dr
Code information
Batch numbers: a) 20180393, exp. date 01/31/2020, 20180424, exp. date 02/29/2020, 20180425, exp. date 02/29/2020, 20180427, exp. date 02/29/2020; b) 20180338, exp. date 12/31/2019, 20180386, exp. date 01/31/2020
Postal code
07430-2009
Report date
Jan 16, 2019
Product type
Drugs
Recall number
D-0350-2019
Classification
Class II
Recalling firm
Glenmark Pharmaceuticals Inc., USA
Product quantity
96,240 applicators
Termination date
Oct 6, 2020
Reason for recall
Defective Delivery System: Customer complaints of malfunctioning plunger of the applicator
Voluntary / mandated
Voluntary: Firm initiated
Product description
Estradiol Vaginal Inserts, USP, 10 mcg, Rx only, packaged in a) 8 count (NDC 68462-711-71) and b) 18 count (NDC 68462-711-88) cartons, Manufactured by: Glenmark Pharmaceuticals, Ltd., Colvale, Goa India, Manufactured for: Glenmark Pharmaceuticals, Inc., USA Mahwah, NJ
Distribution pattern
Product was distributed to 5 retailers and 4 distributors throughout the United States who may have further distributed the recalled product.
Recall initiation date
Dec 26, 2018
Initial firm notification
Letter
Center classification date
Jan 8, 2019

How we source this data

Source: U.S. Food and Drug Administration enforcement report D-0350-2019, published Jan 16, 2019. View the source record (openFDA) · FDA enforcement reports

Last checked against FDA data: . Content last changed: .

FindMyRecall is an independent service and is not affiliated with or endorsed by the FDA. This page simplifies the official record; the FDA or manufacturer notice is authoritative, so follow its instructions. Medication information here is not individualized medical advice.

How we source and update recall data · Report incorrect information

Other recent drug recalls